PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
22797606-12	2012	Differences could be observed by comparing animals treated with AbM to those treated with AmpB, as indicated by a significant reduction in tissue parasitism, higher levels of IFN-gamma and NO, and lower levels of IL-4 and IL-10, as well as by a decreased hepatic toxicity.	Amphotericin B	90-94	interleukin 10	Mus musculus	222-227	
18606693-0	2008	Complete cure of experimental visceral leishmaniasis with amphotericin B in stearylamine-bearing cationic liposomes involves down-regulation of IL-10 and favorable T cell responses.	Amphotericin B	58-72	interleukin 10	Mus musculus	144-149	
18606693-9	2008	This IL-10-deficient environment of IFN-gamma-secreting T cells probably up-regulated the enhanced IL-12 and NO production observed in splenic culture supernatants of these mice, correlating with prolonged disease suppression better than free AmB and AmBisome.	Amphotericin B	243-246	interleukin 10	Mus musculus	5-10	
35436397-3	2022	We observed that low doses with short duration of Amph B as a therapy regime significantly enhanced the induction of Th1 cytokine (INF-gamma), but suppressed Th2 cytokine (IL-10) production.	Amphotericin B	50-56	interleukin 10	Mus musculus	172-177	
35436397-4	2022	Groups of mice infected with L. donovani and treated with Amph B showed clearly increasing in INF-gamma level and reduction in IL-10 level in concentration (3, 4, 5 mg/ml/kg) with best result in 5 mg/ml/kg (accumulation dose 25 mg/ml) than concentrations (6, 7 mg/ml/kg).	Amphotericin B	58-64	interleukin 10	Mus musculus	127-132